About

RepliCel Life Sciences Inc. (TSXV: RP) is a regenerative medicine company focused on developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function such as chronic tendinosis, damaged skin and male pattern baldness.

RepliCel Life Sciences Inc. (RP.V)
Last Traded
3:40pm - 1.45
Volume
20,400
Open
1.51
Previous Close
1.47
Bid
1.43
Ask
1.47
Bid Size
N/A
Ask Size
N/A
Market Cap
21.64M
Shares Owned
N/A
Peg Ratio
0.00
Dividend Yield
N/A
Events & Conferences